Cyclacel Pharmaceuticals, Inc. 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 9, 2015
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Option
2015-12-07+437,569→ 437,569 totalExercise: $0.59Exp: 2025-12-07→ Common Stock (437,569 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted to Mr. Rombotis under the Issuer's 2015 Equity Incentive Plan as part of the Issuer's annual compensation review to executive officers.